Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
New Yamuna Vihar facility to train 40 students annually through diploma-led, hands-on renal care education
Strong limited rollout adoption across major hospital networks positions company for accelerated scale-up in interventional radiology
The companies plan to advance multiple solid tumor targets from Regeneron’s antibody portfolio
GoodRx at a starting price of $149 per month—aligned with the lowest available discounted cash price at launch. The rollout includes nationwide pharmacy access
The launch saw the presence of senior clinicians and leadership from the Manipal Hospitals network
BioNTech will supply pumitamig, a PD-L1/VEGF-A bispecific antibody co-developed with Bristol Myers Squibb, while Boehringer Ingelheim will act as the regulatory sponsor of a Phase Ib/II study
The study’s multi-technology design is intended to improve reproducibility, strengthen regulatory-grade evidence generation
Workshop on ECG interpretation also marks launch of “Handbook on ECGs – Volume 2”
Subscribe To Our Newsletter & Stay Updated
